| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.3 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |